A randomized, double-blind, placebo controlled dose ranging, parallel study to compare the safety, tolerability and pharmacokinetics of 3 doses of AD 452 in adult subjects with rheumatoid arthritis on a background of stable DMARD therapy.

Pilipovic, Nada; Damjanov, Nemanja S; Petrovic, Radmila R; Radunovic, Lazar; Dimic, Aleksandar N; Huber, B; Kirkpatrick, James C; Baker, H; TansleY, R; Sharpington, T

Rezultati

eNauka > Rezultati > A randomized, double-blind, placebo controlled dose ranging, parallel study to compare the safety, tolerability and pharmacokinetics of 3 doses of AD 452 in adult subjects with rheumatoid arthritis on a background of stable DMARD therapy.

Naziv:	A randomized, double-blind, placebo controlled dose ranging, parallel study to compare the safety, tolerability and pharmacokinetics of 3 doses of AD 452 in adult subjects with rheumatoid arthritis on a background of stable DMARD therapy.
Autori:	Pilipovic, Nada; Damjanov, Nemanja S; Petrovic, Radmila R; Radunovic, Lazar; Dimic, Aleksandar N; Huber, B; Kirkpatrick, James C; Baker, H; TansleY, R; Sharpington, T
Godina:	2006
Publikacija:	ARTHRITIS AND RHEUMATISM
ISSN:	0004-3591 Arthritis and Rheumatism Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 54 br. 9 str. S412-S412
WoS-ID:	000240877202092
URI:	https://enauka.gov.rs/handle/123456789/799261
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.